By: Chang Ming-hsuan and Chiang Yi-ching
Of the 14 COVID-19 patients the NRICM has helped treat, 12 were discharged from the hospital within 8-10 days of when the drugs were first given to patients, and they have not shown side affects from the medications so far, NRICM Director Su Yi-Chang (蘇奕彰) told CNA in an interview.
The other two patients were only confirmed with the disease recently, Su said, so they are still undergoing treatment.
Though the mix seems promising, Su did not disclose the specific medications used and said they would only be revealed by the research team when they are included in the Central Epidemic Command Center's (CECC) treatment guidelines. [FULL STORY]